News Search Results
Aug 26, 2024, 17:15 ET Telehealth Market to Grow by USD 368.7 Billion from 2024-2028, Driven by Rising Chronic Disease Cases, AI-Powered Market Evolution- Report by Technavio
integration, and regulatory compliance. Radiology, cardiology, behavioral health, pathology, neurology, dermatology, surgery, gynecology, orthopedics, ophthalmology, and hospital telehealth segments are expanding. Cost savings, improved access, and better patient care drive the market growth.For
More news about: Technavio
Aug 26, 2024, 13:42 ET UL Solutions and Eyesafe Join Forces to Advance Blue Light and Privacy Screen Protector Performance
world-class team of eye doctors, engineers, and scientists with decades of experience in electronics, display materials, light management, optometry, and ophthalmology. The Eyesafe brand is trusted by consumers and integrated in millions of digital devices from Dell, HP, Lenovo, LG, ZAGG and more. Eyesafe is recognized
More news about: Eyesafe
Aug 26, 2024, 10:30 ET AMSURG, LifeBridge Health and Woodholme Group Partner to Open the EndoCentre of Westminster in Westminster, Maryland
health systems, the organization delivers high-quality patient care across a diverse spectrum of medical specialties, including gastroenterology, ophthalmology and orthopedics. With a focus on strategic growth and innovation, AMSURG is committed to transforming the future of ambulatory surgery center care
More news about: AMSURG
Aug 26, 2024, 03:00 ET SIFI reçoit l'approbation de la Commission européenne pour AKANTIOR®
grave et débilitante », déclare le professeur John Dart, du Moorfields Eye Hospital et de l'UCL Institute of Ophthalmology, qui était le chercheur principal de l'essai ODKA de phase III. « Après 15 années de R&D par SIFI, qui ont abouti à l'essai clinique de
More news about: SIFI S.p.A.
Aug 26, 2024, 03:00 ET SIFI recibe la aprobación de la Comisión Europea para AKANTIOR®
enfermedad grave y debilitante", afirmó el profesor John Dart, del Moorfields Eye Hospital y del UCL Institute of Ophthalmology, que fue el investigador principal del ensayo de fase III ODAK. "Tras 15 años de investigación y desarrollo por parte de SIFI, que culminaron
More news about: SIFI S.p.A.
Aug 26, 2024, 03:00 ET SIFI Receives European Commission Approval for AKANTIOR®
severe and debilitating disease," stated Professor John Dart, of Moorfields Eye Hospital and the UCL Institute of Ophthalmology, who was Principal Investigator of the Phase III ODAK trial. "After 15 years of research and effort development by SIFI, culminating in the
More news about: SIFI S.p.A.
Aug 26, 2024, 03:00 ET SIFI erhält die Zulassung der Europäischen Kommission für AKANTIOR®
schwächende Krankheit zu werden", erklärte Professor John Dart vom Moorfields Eye Hospital und dem UCL Institute of Ophthalmology, der die Phase-III-Studie ODAK leitete. „Nach 15 Jahren Forschung und Entwicklung durch SIFI, die in der entscheidenden klinischen Phase-III-Studie
More news about: SIFI S.p.A.
Aug 26, 2024, 03:00 ET SIFI Receives European Commission Approval for AKANTIOR®
severe and debilitating disease," stated Professor John Dart, of Moorfields Eye Hospital and the UCL Institute of Ophthalmology, who was Principal Investigator of the Phase III ODAK trial. "After 15 years of research and effort development by SIFI, culminating in the
More news about: SIFI S.p.A.
Aug 22, 2024, 05:36 ET Ophthalmic Lens Market size is set to grow by USD 13.3 billion from 2024-2028, Increasing prevalence of refractive errors boost the market, AI Role and Impact, Technavio
expected to continue, driving the expansion of the global ophthalmic lens market during the forecast period. The Ophthalmic Lens Market in the ophthalmology sector is experiencing significant growth due to increasing eye disorders caused by extended screen time, both in schools and beyond. Eye clinics
More news about: Technavio
Aug 21, 2024, 20:00 ET China's First Approved KRAS G12C Inhibitor: Innovent Announces the Approval of Dupert® (Fulzerasib) by the National Medical Products Administration of China
that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that China's National Medical Products Administration (NMPA) has approved Dupert®（fulzerasib）for the treatment
More news about: Innovent Biologics
Aug 20, 2024, 07:03 ET VANTEDGE MEDICAL COMPLETES STRATEGIC ACQUISITION OF HOBSON & MOTZER
manufacturing of surgical stapler anvils, complements our existing strengths serving the Robotic Assisted Surgery, Surgical Instrumentation, Orthopedics, Ophthalmology, Dental, Drug Delivery and Medical Diagnostics markets." "As I contemplated transitioning the company to new ownership, my key requirements
More news about: Aterian Investment Partners
Aug 19, 2024, 09:30 ET SalioGen Therapeutics Appoints Kali Stasi, M.D., Ph.D. as Chief Medical Officer
University of Pennsylvania as an Assistant Professor of Ophthalmology. Dr. Stasi earned her M.D. and Ph.D. in neurodegenerative disease from the University of Patras, Greece. She completed an ophthalmology residency at the University of Rochester,
More news about: SalioGen Therapeutics
Aug 16, 2024, 08:00 ET Covenant High Plains Surgery Center earns Optum Bariatric Center of Excellence designation from the Clinical Sciences Institute
well as advanced surgical treatment options in bariatrics, ENT, general surgery, GI, gynecology, interventional pain, neuro & spine surgery, ophthalmology, orthopedics, maxillofacial, plastic & reconstructive surgery, podiatry, and urology to patients from Texas,
More news about: Covenant High Plains Surgery Center
Aug 14, 2024, 16:01 ET Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results
Dr. Chang joins Kodiak from Genentech, a member of the Roche Group, where she was responsible for Genentech's early-stage ophthalmology pipeline. Dr. Chang brings deep ophthalmology experience in support of Kodiak's early-stage research programs and late-phase Phase 3 programs. From inside the organization,
More news about: Kodiak Sciences Inc.
Aug 14, 2024, 10:23 ET Medicus IT Announces Supplier Agreement with EyeProGPO to Enhance Services Reach
Through this partnership, Medicus, already a leader in the ophthalmology space and renowned for aiding ophthalmology practices nationwide with cutting-edge technology tailored to the needs of providers, patients, and staff, will expand its
More news about: Medicus IT
Aug 14, 2024, 08:00 ET Veridix AI, part of Emmes Group, Announces New Protocol Digitization Capabilities
companies throughout the world. The company has built industry leading capabilities in cell and gene therapy, vaccines and infectious diseases, ophthalmology, and neuroscience. Today, we are part of the Emmes Group, helping transform the future of clinical research. Learn more at
More news about: EMMES
Aug 14, 2024, 08:00 ET Veridix AI, part of Emmes Group, Announces New Protocol Digitization Capabilities
companies throughout the world. The company has built industry leading capabilities in cell and gene therapy, vaccines and infectious diseases, ophthalmology, and neuroscience. Today, we are part of the Emmes Group, helping transform the future of clinical research. Learn more at
More news about: EMMES
Aug 13, 2024, 11:06 ET Spencer Trask & Co. Launches Dry Eye Venture Signal12 with Former Aerie Pharmaceutical Executives Thomas Mitro and Marvin Garrett
NY Presbyterian where she is a Clinical Professor of Ophthalmology at the Edward Harkness Eye Institute of NY Presbyterian Columbia University Medical Center. She is an examiner for the American Board of Ophthalmology, a Heed Foundation Fellow, and was a member of the White
More news about: Spencer Trask & Co.
Aug 13, 2024, 09:00 ET ZEISS expands Micro-CT research pipeline with the Beckman Institute for Advanced Science and Technology
assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture
More news about: ZEISS Research Microscopy Solutions
Aug 13, 2024, 09:00 ET PM360 Announces 2024 Trailblazer Award Finalists
Health: Katie Lewandroski, Executive Director, Oncology Marketing Lead (Sumitomo Pharma America) Ophthalmology/Optometry: Liz Tempesta, Senior Director, Consumer Marketing, Eye Care Division (Viatris) OTC Marketer:
More news about: PM360
Aug 12, 2024, 09:56 ET OcuMension acquires rights to Alcon eye drops in exchange for a 16.7% equity stake, signaling the commencement of comprehensive strategic relationship
promote technological advancements and innovations in the field of ophthalmology. Ophthalmic diseases are internationally recognized as one of the highly focused medical sub-sectors, with innovative treatment solutions for ophthalmology still awaiting development. Based on this, OcuMension will continue
More news about: OcuMension
Aug 08, 2024, 07:05 ET REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
announced it will participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference on Thursday, August 15, 2024. H.C. Wainwright 4th Annual Ophthalmology Virtual ConferencePanel: The Evolving Therapeutic Landscape
More news about: REGENXBIO Inc.
Aug 08, 2024, 07:00 ET Nanoscope Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
2024 H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, taking place on August 15, 2024.
More news about: Nanoscope Therapeutics
Aug 07, 2024, 08:00 ET Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States
acute dry eye indication could expand the use of clobetasol among the millions of people who experience flare-ups. According to American Academy of Ophthalmology, about 80% of patients suffering from dry eye experience flare-ups. IQVIA estimates that approximately 2 million people are treated with prescription
More news about: Formosa Pharmaceuticals Inc.,
Aug 07, 2024, 08:00 ET Constitution Surgery Alliance ASC Facilities Achieve 12,000th Total Joint Arthroplasty Milestone
News & World Report named two CSA surgery centers to its inaugural "Best Ambulatory Surgery Centers" list: East Bay Surgery Center (Best Ophthalmology ASC category) and Middlesex Endoscopy Center (Best Colonoscopy/Endoscopy ASC category). In December, The Leapfrog Group, an independent national
More news about: Constitution Surgery Alliance